Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 398

1.

The dicey dinner dilemma: Asymmetry in predator-prey risk-taking, a broadly applicable alternative to the life-dinner principle.

Humphreys RK, Ruxton GD.

J Evol Biol. 2020 Mar;33(3):377-383. doi: 10.1111/jeb.13585. Epub 2020 Jan 29.

PMID:
31919916
2.

Recruitment dynamics and fishery characteristics of juvenile goatfishes Mulloidichthys spp. in Hawai'i.

Kamikawa KT, Humphreys RL Jr, Bowen BW, Friedlander AM.

J Fish Biol. 2019 Oct;95(4):1086-1093. doi: 10.1111/jfb.14101. Epub 2019 Aug 5.

PMID:
31314922
3.

Hybridization in human evolution: Insights from other organisms.

Ackermann RR, Arnold ML, Baiz MD, Cahill JA, Cortés-Ortiz L, Evans BJ, Grant BR, Grant PR, Hallgrimsson B, Humphreys RA, Jolly CJ, Malukiewicz J, Percival CJ, Ritzman TB, Roos C, Roseman CC, Schroeder L, Smith FH, Warren KA, Wayne RK, Zinner D.

Evol Anthropol. 2019 Jul;28(4):189-209. doi: 10.1002/evan.21787. Epub 2019 Jun 20. Review.

PMID:
31222847
4.

Adaptive suicide: is a kin-selected driver of fatal behaviours likely?

Humphreys RK, Ruxton GD.

Biol Lett. 2019 Feb 28;15(2):20180823. doi: 10.1098/rsbl.2018.0823. Review.

5.

Normal Blood Glucose and High Blood Ketones in a Critically Unwell Patient with T1DM Post-Bariatric Surgery: a Case of Euglycemic Diabetic Ketoacidosis.

Dowsett J, Humphreys R, Krones R.

Obes Surg. 2019 Jan;29(1):347-349. doi: 10.1007/s11695-018-3548-6.

PMID:
30328578
6.

Dropping to escape: a review of an under-appreciated antipredator defence.

Humphreys RK, Ruxton GD.

Biol Rev Camb Philos Soc. 2019 Apr;94(2):575-589. doi: 10.1111/brv.12466. Epub 2018 Oct 9. Review.

PMID:
30298642
7.

Interprofessional simulation training for community mental health teams: Findings from a mixed methods study.

Piette AE, Attoe C, Humphreys R, Cross S, Kowalski C.

J Interprof Care. 2018 Aug 24:1-9. doi: 10.1080/13561820.2018.1511524. [Epub ahead of print]

PMID:
30142281
8.

Underestimation of Pearson's product moment correlation statistic.

Humphreys RK, Puth MT, Neuhäuser M, Ruxton GD.

Oecologia. 2019 Jan;189(1):1-7. doi: 10.1007/s00442-018-4233-0. Epub 2018 Jul 30.

9.

Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome.

Wachman EM, Grossman M, Schiff DM, Philipp BL, Minear S, Hutton E, Saia K, Nikita F, Khattab A, Nolin A, Alvarez C, Barry K, Combs G, Stickney D, Driscoll J, Humphreys R, Burke J, Farrell C, Shrestha H, Whalen BL.

J Perinatol. 2018 Aug;38(8):1114-1122. doi: 10.1038/s41372-018-0109-8. Epub 2018 May 8.

PMID:
29740196
10.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL, Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C, Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P, Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK, Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E, Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID:
29672835
11.

Craniomandibular form and body size variation of first generation mouse hybrids: A model for hominin hybridization.

Warren KA, Ritzman TB, Humphreys RA, Percival CJ, Hallgrímsson B, Ackermann RR.

J Hum Evol. 2018 Mar;116:57-74. doi: 10.1016/j.jhevol.2017.12.002. Epub 2018 Feb 8.

12.

A review of thanatosis (death feigning) as an anti-predator behaviour.

Humphreys RK, Ruxton GD.

Behav Ecol Sociobiol. 2018;72(2):22. doi: 10.1007/s00265-017-2436-8. Epub 2018 Jan 15. Review.

13.

Consequences of grouped data for testing for departure from circular uniformity.

Humphreys RK, Ruxton GD.

Behav Ecol Sociobiol. 2017;71(11):167. doi: 10.1007/s00265-017-2393-2. Epub 2017 Oct 28.

14.

Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Simpson E, Apfelbacher CJ, Thomas KS, von Kobyletzki L, Schmitt J, Singh JA, Svensson Å, Williams HC, Abuabara K, Aoki V, Ardeleanu M, Awici-Rasmussen M, Barbarot S, Berents TL, Block J, Bragg A, Burton T, Bjerring Clemmensen KK, Creswell-Melville A, Dinesen M, Drucker A, Eckert L, Flohr C, Garg M, Gerbens LA, Graff AL, Hanifin J, Heinl D, Humphreys R, Ishii HA, Kataoka Y, Leshem YA, Marquort B, Massuel MA, Merhand S, Mizutani H, Murota H, Murrell DF, Nakahara T, Nasr I, Nograles K, Ohya Y, Osterloh I, Pander J, Prinsen C, Purkins L, Ridd M, Sach T, Schuttelaar ML, Shindo S, Smirnova J, Sulzer A, Synnøve Gjerde E, Takaoka R, Vestby Talmo H, Tauber M, Torchet F, Volke A, Wahlgren CF, Weidinger S, Weisshaar E, Wollenberg A, Yamaga K, Zhao CY, Spuls PI.

Br J Dermatol. 2016 Jul;175(1):69-79. doi: 10.1111/bjd.14773. Epub 2016 Jul 19.

PMID:
27436240
15.

Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review.

Heinl D, Prinsen CA, Drucker AM, Ofenloch R, Humphreys R, Sach T, Flohr C, Apfelbacher C.

Syst Rev. 2016 Feb 9;5:25. doi: 10.1186/s13643-016-0202-z.

16.

A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma.

Ciuleanu T, Bazin I, Lungulescu D, Miron L, Bondarenko I, Deptala A, Rodriguez-Torres M, Giantonio B, Fox NL, Wissel P, Egger J, Ding M, Kalyani RN, Humphreys R, Gribbin M, Sun W.

Ann Oncol. 2016 Apr;27(4):680-7. doi: 10.1093/annonc/mdw004. Epub 2016 Jan 22.

17.

Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review.

Heinl D, Prinsen CA, Deckert S, Chalmers JR, Drucker AM, Ofenloch R, Humphreys R, Sach T, Chamlin SL, Schmitt J, Apfelbacher C.

Allergy. 2016 Mar;71(3):358-70. doi: 10.1111/all.12806. Epub 2015 Dec 16. Review.

PMID:
26564008
18.

Revision of Breastfeeding Guidelines in the Setting of Maternal Opioid Use Disorder: One Institution's Experience.

Wachman EM, Saia K, Humphreys R, Minear S, Combs G, Philipp BL.

J Hum Lact. 2016 May;32(2):382-7. doi: 10.1177/0890334415613823. Epub 2015 Oct 29.

PMID:
26514156
19.

Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib.

Neeson PJ, Hsu AK, Chen YR, Halse HM, Loh J, Cordy R, Fielding K, Davis J, Noske J, Davenport AJ, Lindqvist-Gigg CA, Humphreys R, Tai T, Prince HM, Trapani JA, Smyth MJ, Ritchie DS.

Oncoimmunology. 2015 May 27;4(9):e1038011. eCollection 2015 Sep.

20.

Measurement properties of adult quality-of-life measurement instruments for eczema: protocol for a systematic review.

Apfelbacher CJ, Heinl D, Prinsen CA, Deckert S, Chalmers J, Ofenloch R, Humphreys R, Sach T, Chamlin S, Schmitt J.

Syst Rev. 2015 Apr 16;4:48. doi: 10.1186/s13643-015-0041-3.

21.

Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME).

Chalmers JR, Schmitt J, Apfelbacher C, Dohil M, Eichenfield LF, Simpson EL, Singh J, Spuls P, Thomas KS, Admani S, Aoki V, Ardeleanu M, Barbarot S, Berger T, Bergman JN, Block J, Borok N, Burton T, Chamlin SL, Deckert S, DeKlotz CC, Graff LB, Hanifin JM, Hebert AA, Humphreys R, Katoh N, Kisa RM, Margolis DJ, Merhand S, Minnillo R, Mizutani H, Nankervis H, Ohya Y, Rodgers P, Schram ME, Stalder JF, Svensson A, Takaoka R, Teper A, Tom WL, von Kobyletzki L, Weisshaar E, Zelt S, Williams HC.

Br J Dermatol. 2014 Dec;171(6):1318-25. doi: 10.1111/bjd.13237. Epub 2014 Nov 14.

22.

Low-flow mediated constriction: the yin to FMD's yang?

Humphreys RE, Green DJ, Cable NT, Thijssen DH, Dawson EA.

Expert Rev Cardiovasc Ther. 2014 May;12(5):557-64. doi: 10.1586/14779072.2014.909728. Epub 2014 Apr 18. Review.

PMID:
24745959
23.

When and how to treat patients who refuse treatment.

Humphreys RA, Lepper R, Nicholson TR.

BMJ. 2014 Mar 25;348:g2043. doi: 10.1136/bmj.g2043. No abstract available. Erratum in: BMJ. 2014;348:g3501.

PMID:
24668621
24.

Phase II trial of mapatumumab, a fully human agonist monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1), in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

von Pawel J, Harvey JH, Spigel DR, Dediu M, Reck M, Cebotaru CL, Humphreys RC, Gribbin MJ, Fox NL, Camidge DR.

Clin Lung Cancer. 2014 May;15(3):188-196.e2. doi: 10.1016/j.cllc.2013.12.005. Epub 2013 Dec 27.

PMID:
24560012
25.

Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis.

Abdulghani J, Allen JE, Dicker DT, Liu YY, Goldenberg D, Smith CD, Humphreys R, El-Deiry WS.

PLoS One. 2013 Sep 26;8(9):e75414. doi: 10.1371/journal.pone.0075414. eCollection 2013.

26.

WITHDRAWN: Chinese herbal medicine for atopic eczema.

Zhang W, Leonard T, Bath-Hextall FJ, Chambers C, Lee C, Humphreys R, Williams HC.

Cochrane Database Syst Rev. 2013 Sep 11;(9):CD002291. doi: 10.1002/14651858.CD002291.pub4. Review. No abstract available.

PMID:
24027064
27.

Oral evening primrose oil and borage oil for eczema.

Bamford JT, Ray S, Musekiwa A, van Gool C, Humphreys R, Ernst E.

Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004416. doi: 10.1002/14651858.CD004416.pub2. Review.

PMID:
23633319
28.

Fusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivo.

Luster TA, Mukherjee I, Carrell JA, Cho YH, Gill J, Kelly L, Garcia A, Ward C, Oh L, Ullrich SJ, Migone TS, Humphreys R.

PLoS One. 2012;7(10):e47361. doi: 10.1371/journal.pone.0047361. Epub 2012 Oct 9.

29.

Modern shutters can be a thing of beauty.

Humphreys R.

Health Estate. 2012 Sep;66(8):63-5.

PMID:
23009020
30.
31.

Mitomycin C potentiates TRAIL-induced apoptosis through p53-independent upregulation of death receptors: evidence for the role of c-Jun N-terminal kinase activation.

Cheng H, Hong B, Zhou L, Allen JE, Tai G, Humphreys R, Dicker DT, Liu YY, El-Deiry WS.

Cell Cycle. 2012 Sep 1;11(17):3312-23. doi: 10.4161/cc.21670. Epub 2012 Aug 16.

32.

RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex.

Abhari BA, Cristofanon S, Kappler R, von Schweinitz D, Humphreys R, Fulda S.

Oncogene. 2013 Jul 4;32(27):3263-73. doi: 10.1038/onc.2012.337. Epub 2012 Aug 13.

PMID:
22890322
33.

Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting.

Schmitt J, Spuls P, Boers M, Thomas K, Chalmers J, Roekevisch E, Schram M, Allsopp R, Aoki V, Apfelbacher C, Bruijnzeel-Koomen C, Bruin-Weller M, Charman C, Cohen A, Dohil M, Flohr C, Furue M, Gieler U, Hooft L, Humphreys R, Ishii HA, Katayama I, Kouwenhoven W, Langan S, Lewis-Jones S, Merhand S, Murota H, Murrell DF, Nankervis H, Ohya Y, Oranje A, Otsuka H, Paul C, Rosenbluth Y, Saeki H, Schuttelaar ML, Stalder JF, Svensson A, Takaoka R, Wahlgren CF, Weidinger S, Wollenberg A, Williams H.

Allergy. 2012 Sep;67(9):1111-7. doi: 10.1111/j.1398-9995.2012.02874.x. Epub 2012 Jul 30.

PMID:
22844983
34.

Pediatric neurosurgery at the Hospital for Sick Children, The University of Toronto.

Rutka JT, Drake J, Dirks P, Kulkarni A, Taylor M, Humphreys RP.

Childs Nerv Syst. 2012 Aug;28(8):1127-8. doi: 10.1007/s00381-012-1855-0. No abstract available.

PMID:
22810275
35.

The Great Eruption of η Carinae.

Davidson K, Humphreys RM.

Nature. 2012 Jun 20;486(7403):E1; discussion E1-2. doi: 10.1038/nature11166.

PMID:
22722207
36.

Pregnancy outcomes among solid organ transplant recipients in British Columbia.

Humphreys RA, Wong HHL, Milner R, Matsuda-Abedini M.

J Obstet Gynaecol Can. 2012 May;34(5):416-424. doi: 10.1016/S1701-2163(16)35237-9.

PMID:
22555133
37.

Dietary supplements for established atopic eczema.

Bath-Hextall FJ, Jenkinson C, Humphreys R, Williams HC.

Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005205. doi: 10.1002/14651858.CD005205.pub3. Review.

PMID:
22336810
38.

Cranial neural crest ablation of Jagged1 recapitulates the craniofacial phenotype of Alagille syndrome patients.

Humphreys R, Zheng W, Prince LS, Qu X, Brown C, Loomes K, Huppert SS, Baldwin S, Goudy S.

Hum Mol Genet. 2012 Mar 15;21(6):1374-83. doi: 10.1093/hmg/ddr575. Epub 2011 Dec 8. Erratum in: Hum Mol Genet. 2012 Jun 15;21(12):2843.

39.

Prevalence, course and associations of desire for hastened death in a UK palliative population: a cross-sectional study.

Price A, Lee W, Goodwin L, Rayner L, Humphreys R, Hansford P, Sykes N, Monroe B, Higginson I, Hotopf M.

BMJ Support Palliat Care. 2011 Sep;1(2):140-8. doi: 10.1136/bmjspcare-2011-000011. Epub 2011 Jul 4.

PMID:
24653226
40.

Prediction of proapoptotic anticancer therapeutic response in vivo based on cell death visualization and TRAIL death ligand-receptor interaction.

Zhou L, Wang W, Dicker DT, Humphreys RC, El-Deiry WS.

Cancer Biol Ther. 2011 Aug 15;12(4):335-48. Epub 2011 Aug 15.

PMID:
21785270
41.

Spectral imaging-based methods for quantifying autophagy and apoptosis.

Dolloff NG, Ma X, Dicker DT, Humphreys RC, Li LZ, El-Deiry WS.

Cancer Biol Ther. 2011 Aug 15;12(4):349-56. Epub 2011 Aug 15.

42.

Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.

Dolloff NG, Mayes PA, Hart LS, Dicker DT, Humphreys R, El-Deiry WS.

Sci Transl Med. 2011 Jun 8;3(86):86ra50. doi: 10.1126/scitranslmed.3001384.

43.

Perceptions of first year foundation dentists on oral health education and its role in general dental practice.

Humphreys RE, Richards W, Gill P.

Br Dent J. 2010 Dec 18;209(12):601-6. doi: 10.1038/sj.bdj.2010.1133.

PMID:
21169964
44.

TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors.

Stadel D, Mohr A, Ref C, MacFarlane M, Zhou S, Humphreys R, Bachem M, Cohen G, Möller P, Zwacka RM, Debatin KM, Fulda S.

Clin Cancer Res. 2010 Dec 1;16(23):5734-49. doi: 10.1158/1078-0432.CCR-10-0985. Epub 2010 Oct 12.

45.

Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.

Dobson CL, Main S, Newton P, Chodorge M, Cadwallader K, Humphreys R, Albert V, Vaughan TJ, Minter RR, Edwards BM.

MAbs. 2009 Nov-Dec;1(6):552-62. Epub 2009 Nov 11.

46.

Tumor Necrosis Factor-related apoptosis-inducing ligand (TRAIL) Receptor-1 and Receptor-2 agonists for cancer therapy.

Fox NL, Humphreys R, Luster TA, Klein J, Gallant G.

Expert Opin Biol Ther. 2010 Jan;10(1):1-18. doi: 10.1517/14712590903319656. Review.

PMID:
19857186
47.

Upper limb motor function in young adults with spina bifida and hydrocephalus.

Dennis M, Salman MS, Jewell D, Hetherington R, Spiegler BJ, MacGregor DL, Drake JM, Humphreys RP, Gentili F.

Childs Nerv Syst. 2009 Nov;25(11):1447-53. doi: 10.1007/s00381-009-0948-x. Epub 2009 Aug 12.

48.

Efficacy of triple therapies including ionising radiation, agonistic TRAIL antibodies and cisplatin.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C.

Oncol Rep. 2009 Jun;21(6):1455-60.

PMID:
19424623
49.

A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR.

Ren B, Song K, Parangi S, Jin T, Ye M, Humphreys R, Duquette M, Zhang X, Benhaga N, Lawler J, Khosravi-Far R.

Cancer Res. 2009 May 1;69(9):3856-65. doi: 10.1158/0008-5472.CAN-08-2940. Epub 2009 Apr 14.

50.

Peptide aptamers in label-free protein detection: 2. Chemical optimization and detection of distinct protein isoforms.

Davis JJ, Tkac J, Humphreys R, Buxton AT, Lee TA, Ko Ferrigno P.

Anal Chem. 2009 May 1;81(9):3314-20. doi: 10.1021/ac802513n.

PMID:
19320493

Supplemental Content

Loading ...
Support Center